PHARMACEUTICAL USES OF NAB1 AND NAB2 - Patent 1097200

(19)

(11)

EP 1 097 200 A1

(12)

(43)	Date of publication:
	09.05.2001 Bulletin 2001/19

(21)	Application number: 99931378.6

(22)	Date of filing: 09.07.1999

(51)	International Patent Classification (IPC)⁷: C12N 15/12, A61K 48/00, A61K 38/17

(86)	International application number:
	PCT/GB9902/199

(87)	International publication number:
	WO 0003/014 (20.01.2000 Gazette 2000/03)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

11.07.1998 GB 9814989
12.09.1998 GB 9819826

(71)	Applicant: GLAXO GROUP LIMITED
	Greenford, Middlesex UB6 ONN (GB)

(72)	Inventors:
	BRADDOCK, Martin Stevenage,Hertfordshire SG1 2NY (GB) CAMPBELL, Callum Jeffrey Stevenage,Hertfordshire SG1 2NY (GB)

(74)	Representative: Hammett, Audrey Grace Campbell et al
	Glaxo Wellcome plc,Glaxo Wellcome House,Berkeley Avenue Greenford,Middlesex UB6 0NN Greenford,Middlesex UB6 0NN (GB)

(54)	PHARMACEUTICAL USES OF NAB1 AND NAB2